Back to Browse Journals » Clinical Ophthalmology » Volume 2 » Issue 1

Clinical treatment options for patients with homonymous visual field defects

Authors Alison R Lane, Daniel T Smith, Thomas Schenk

Published 7 March 2008 Volume 2008:2(1) Pages 93—102

DOI http://dx.doi.org/10.2147/OPTH.S2371

Alison R Lane, Daniel T Smith, Thomas Schenk

Cognitive Neuroscience Research Unit, Durham University, Durham, UK

Abstract: The objective of this review is to evaluate treatments for homonymous visual field defects (HVFDs). We distinguish between three treatments: visual restoration training (VRT), optical aids, and compensatory training. VRT is both the most ambitious and controversial approach, aiming to restore portions of the lost visual field. While early studies suggested that VRT can reduce the visual field defect, recent studies using more reliable means of monitoring the patients’ fixation could not confirm this effect. Studies utilizing modern optical aids have reported some promising results, but the extent to which these aids can reliably reduce the patients’ visual disability has yet to be confirmed. Compensatory approaches, which teach patients more effective ways of using their eyes, are currently the only form of treatment for which behavioral improvements have been demonstrated. However, with the exception of one study using a reading training, placebo-controlled clinical evaluation studies are lacking. It is also not yet clear whether the training benefits found in laboratory tasks lead to reliable improvements in activities of daily living and which of the various forms of compensatory training is the most promising. It is therefore too early to recommend any of the currently available treatment approaches.

Keywords: homonymous hemianopia, rehabilitation, treatment outcome

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Severe hypernatremia and hyperchloremia in an elderly patient with IgG-kappa-type multiple myeloma

Imashuku S, Kudo N, Kubo K

Journal of Blood Medicine 2013, 4:43-47

Published Date: 14 May 2013

Anacetrapib: potential for the prevention and treatment of coronary heart disease

Steen DL, Khera AV, Cannon CP

Research Reports in Clinical Cardiology 2013, 4:39-53

Published Date: 4 April 2013

A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma

Garcia-Feijoo J, Sampaolesi JR

Clinical Ophthalmology 2012, 6:441-446

Published Date: 22 March 2012

The Mozart effect in biofeedback visual rehabilitation: a case report

Salvatore S, Librando A, Esposito M, Vingolo EM

Clinical Ophthalmology 2011, 5:1269-1272

Published Date: 6 September 2011

Four cases of traumatic hypotony maculopathy treated by various methods

Mutoh T, Matsumoto Y, Chikuda M

Clinical Ophthalmology 2011, 5:1223-1226

Published Date: 29 August 2011

Efficacy of amniotic membrane-assisted bleb revision for elevated intraocular pressure after filtering surgery

Yoshiaki Kiuchi, Masahide Yanagi, Takao Nakamura

Clinical Ophthalmology 2010, 4:839-843

Published Date: 23 July 2010

Interferons and their potential in the treatment of ocular inflammation

Friederike Mackensen, Regina Max, Matthias D Becker

Clinical Ophthalmology 2009, 3:559-566

Published Date: 16 October 2009